WithdrawnPhase 2

Study of a Potential New Treatment for Patients With Toxic Epidermal Necrolysis (TEN)

Stopped: slow enrollment

0Started 2006-07

Plain-language summary

To determine whether treatment of patients who have toxic epidermal necrolysis with a drug called remicaide increases the number of patients who are alive 30 days laters.

Who can participate

Age range18 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * Admission to burn unit with a histologic diagnosis of TENs Exclusion Criteria: * Pregnancy * hypersensitivity to remicaide * history of heart failure * documented bacteremia * history of cancer * inability to consent

What they're measuring

30 day mortality

Timeframe: 30 days

Trial details

NCT IDNCT00372723

SponsorLoyola University

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2011-06

View on ClinicalTrials.gov More Toxic Epidermal Necrolysis trials